An Update from the folks at Seventy K: If you live in California Check This Out!
Seventy K is a new campaign to raise awareness about the lack of rights that adolescent and young adult cancer (AYA) patients, those ages 15 to 39, have in the organized medical world. AYA patients, especially those in the younger end of the spectrum, tend to fall through the cracks of being considered either a pediatric or adult cancer patient, and sometimes face gaps in services and treatments. Developed by Dr. Leonard Sender, an AYA Cancer specialist, the SeventyK project includes an AYA-specific Bill of Rights which will ensure that adolescent and young adult cancer patients have adequate and specific treatment programs, similar to those developed for young children and adult cancer patients.
When: Saturday April 12, 2008 from 5-8pm
Where: Dave and Buster’s
20 City Blvd., West Bldg. G, Suite 1 Orange, CA 92686
RSVP: Reserve your space by April 4th by calling 714-289-4735 or emailing firstname.lastname@example.org
CRAZY SEXY CANCER BOOT CAMP, April 18-20, 2008. The Crossings, Austin, Texas. Speakers: Kris Carr, Terri Cole, Peter Gold, Anne Gourley.
“Learn how to successfully navigate the road to recovery as you refuse to let yourself be defined by cancer.”
From the Headlines:
Red Wine Can Kill Cancer Cells: A natural anti-oxidant in grape skins and red wine can help kill cancer cells in the pancreas by crippling the cells’ core energy source, says a new study. (Economic Times, March 27, 2008)
‘World Wide Web of Cancer Research’ exploits human genome map: Research grid could lead to improved drug research and safer clinical trials for cancer patients–and soon for other diseases. (Computerworld, March 26, 2008)
Cancer warning: Please adjust your screening. An ad campaign about colorectal cancer wants Ontarians to get with the program (Ottowa Citizen, March 25, 2008)
MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread-Those having radiation therapy may want to request more aggressive therapy, study finds. (U.S. News & World Report, March 25, 2008)
Amrubicin(R) Receives FDA Orphan Drug Designation For The Treatment Of Small Cell Lung Cancer -(Business Wire, March 25, 2008)
St. Jude study offers new hope for children with kidney tumors deemed inoperable: (Cancernews.com/St. Jude’s Children’s Research Hospital, March 24, 2008)